Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value
Coronavirus disease 2019 (COVID-19) has been chiefly linked with substantial respiratory complications. However, emerging studies have brought attention to the occurrence of severe muscle inflammation (myositis) related to COVID-19, potentially leading to multi-organ failure and increased mortality....
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-12-01
|
| Series: | Infectious Disease Reports |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2036-7449/16/1/2 |
| _version_ | 1797298071101505536 |
|---|---|
| author | Francesco Pizzo Andrea Marino Alessandra Di Nora Serena Spampinato Giovanni Cacciaguerra Giuseppe Costanza Federica Scarlata Arturo Biasco Maria Chiara Consentino Riccardo Lubrano Bruno Cacopardo Giuseppe Nunnari Martino Ruggieri Piero Pavone |
| author_facet | Francesco Pizzo Andrea Marino Alessandra Di Nora Serena Spampinato Giovanni Cacciaguerra Giuseppe Costanza Federica Scarlata Arturo Biasco Maria Chiara Consentino Riccardo Lubrano Bruno Cacopardo Giuseppe Nunnari Martino Ruggieri Piero Pavone |
| author_sort | Francesco Pizzo |
| collection | DOAJ |
| description | Coronavirus disease 2019 (COVID-19) has been chiefly linked with substantial respiratory complications. However, emerging studies have brought attention to the occurrence of severe muscle inflammation (myositis) related to COVID-19, potentially leading to multi-organ failure and increased mortality. Myositis is generally characterized by heightened serum creatine kinase (CK) levels. Acute myositis is characterized by an infiltration of viruses into calf muscle fibers, which may cause a subsequent inflammatory response leading to calf muscle pain. Symptomatic and supportive management, along with explanation and reassurance, is all that is required in managing this condition. While the association between myositis and severe outcomes has been recognized in adults, it remains less understood in the pediatric population. The current retrospective study, conducted at Policlinico San Marco University Hospital in Catania, aimed to analyze clinical and laboratory factors associated with myositis in pediatric patients with SARS-CoV-2 infection. Between January 2022 and January 2023, ten pediatric patients diagnosed with myositis and SARS-CoV-2 infection were evaluated. The study highlighted clinical manifestations such as fever, calf muscle pain, and abnormal gait. Lab results showed elevated CK levels among other findings. All patients underwent treatment, with the majority recovering without complications. A notable correlation was observed between CK levels, blood urea nitrogen (BUN), and the urea/creatinine ratio (UCR). The study also discusses potential pathophysiological mechanisms behind SARS-CoV-2’s impact on skeletal muscles, emphasizing an indirect inflammatory response. Our findings underscore that while myositis in children with SARS-CoV-2 infection appears to follow a benign and self-limiting trajectory, it is crucial to monitor specific markers for early intervention and management. Further research is warranted to elucidate the underlying mechanisms and improve clinical outcomes. |
| first_indexed | 2024-03-07T22:29:33Z |
| format | Article |
| id | doaj.art-49732276668c4fe9bde033f6ed55f8fa |
| institution | Directory Open Access Journal |
| issn | 2036-7449 |
| language | English |
| last_indexed | 2024-03-07T22:29:33Z |
| publishDate | 2023-12-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Infectious Disease Reports |
| spelling | doaj.art-49732276668c4fe9bde033f6ed55f8fa2024-02-23T15:19:02ZengMDPI AGInfectious Disease Reports2036-74492023-12-01161132510.3390/idr16010002Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive ValueFrancesco Pizzo0Andrea Marino1Alessandra Di Nora2Serena Spampinato3Giovanni Cacciaguerra4Giuseppe Costanza5Federica Scarlata6Arturo Biasco7Maria Chiara Consentino8Riccardo Lubrano9Bruno Cacopardo10Giuseppe Nunnari11Martino Ruggieri12Piero Pavone13Postgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyInfectious Diseases Unit, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, 95122 Catania, ItalyPostgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyDepartment of Clinical and Experimental Medicine, University of Messina, 98122 Messina, ItalyPostgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyPostgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyPostgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyPostgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyPostgraduate Training Programme in Pediatrics, Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, 95123 Catania, ItalyDepartment of Paediatrics, Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma, ItalyInfectious Diseases Unit, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, 95122 Catania, ItalyInfectious Diseases Unit, Department of Clinical and Experimental Medicine, ARNAS Garibaldi Hospital, University of Catania, 95122 Catania, ItalyDepartment of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University Hospital “Policlinico G. Rodolico”, 95125 Catania, ItalyDepartment of Clinical and Experimental Medicine, Section of Pediatrics and Child Neuropsychiatry, University Hospital “Policlinico G. Rodolico”, 95125 Catania, ItalyCoronavirus disease 2019 (COVID-19) has been chiefly linked with substantial respiratory complications. However, emerging studies have brought attention to the occurrence of severe muscle inflammation (myositis) related to COVID-19, potentially leading to multi-organ failure and increased mortality. Myositis is generally characterized by heightened serum creatine kinase (CK) levels. Acute myositis is characterized by an infiltration of viruses into calf muscle fibers, which may cause a subsequent inflammatory response leading to calf muscle pain. Symptomatic and supportive management, along with explanation and reassurance, is all that is required in managing this condition. While the association between myositis and severe outcomes has been recognized in adults, it remains less understood in the pediatric population. The current retrospective study, conducted at Policlinico San Marco University Hospital in Catania, aimed to analyze clinical and laboratory factors associated with myositis in pediatric patients with SARS-CoV-2 infection. Between January 2022 and January 2023, ten pediatric patients diagnosed with myositis and SARS-CoV-2 infection were evaluated. The study highlighted clinical manifestations such as fever, calf muscle pain, and abnormal gait. Lab results showed elevated CK levels among other findings. All patients underwent treatment, with the majority recovering without complications. A notable correlation was observed between CK levels, blood urea nitrogen (BUN), and the urea/creatinine ratio (UCR). The study also discusses potential pathophysiological mechanisms behind SARS-CoV-2’s impact on skeletal muscles, emphasizing an indirect inflammatory response. Our findings underscore that while myositis in children with SARS-CoV-2 infection appears to follow a benign and self-limiting trajectory, it is crucial to monitor specific markers for early intervention and management. Further research is warranted to elucidate the underlying mechanisms and improve clinical outcomes.https://www.mdpi.com/2036-7449/16/1/2SARS-CoV-2 infectionpediatric COVID-19COVID-19 myositisCOVID-19 myolysis |
| spellingShingle | Francesco Pizzo Andrea Marino Alessandra Di Nora Serena Spampinato Giovanni Cacciaguerra Giuseppe Costanza Federica Scarlata Arturo Biasco Maria Chiara Consentino Riccardo Lubrano Bruno Cacopardo Giuseppe Nunnari Martino Ruggieri Piero Pavone Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value Infectious Disease Reports SARS-CoV-2 infection pediatric COVID-19 COVID-19 myositis COVID-19 myolysis |
| title | Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value |
| title_full | Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value |
| title_fullStr | Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value |
| title_full_unstemmed | Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value |
| title_short | Urea/Creatinine Ratio’s Correlation with Creatine Kinase Normalization in Pediatric COVID-19 Patients with Myositis: Evaluating Prognostic and Predictive Value |
| title_sort | urea creatinine ratio s correlation with creatine kinase normalization in pediatric covid 19 patients with myositis evaluating prognostic and predictive value |
| topic | SARS-CoV-2 infection pediatric COVID-19 COVID-19 myositis COVID-19 myolysis |
| url | https://www.mdpi.com/2036-7449/16/1/2 |
| work_keys_str_mv | AT francescopizzo ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT andreamarino ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT alessandradinora ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT serenaspampinato ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT giovannicacciaguerra ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT giuseppecostanza ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT federicascarlata ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT arturobiasco ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT mariachiaraconsentino ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT riccardolubrano ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT brunocacopardo ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT giuseppenunnari ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT martinoruggieri ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue AT pieropavone ureacreatinineratioscorrelationwithcreatinekinasenormalizationinpediatriccovid19patientswithmyositisevaluatingprognosticandpredictivevalue |